Crossmark

The CRISPR-Cas revolution in head and neck cancer: a new era of targeted therapy

Published Online: 2025-05-30

Published Print: 2025-12

Authors

Hashemi, Mohsen

Khanaghah, Xaniar Mohmmadi

Nahand, Javid Sadri
License Information

Text and Data Mining valid from 2025-05-30

Version of Record valid from 2025-05-30
More Information

Article History

Received: 12 January 2025

Revised: 5 May 2025

Accepted: 6 May 2025

First Online: 30 May 2025

Declarations

:

: The authors declare no competing interests.

Document is current